Previous Close | 11.70 |
Open | 11.80 |
Bid | 11.60 x 0 |
Ask | 11.80 x 0 |
Day's Range | 11.30 - 11.80 |
52 Week Range | 6.90 - 17.70 |
Volume | |
Avg. Volume | 3 |
Market Cap | 333.778M |
Beta (5Y Monthly) | 1.95 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.27 |
Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 42.40 |
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
PetIQ (PETQ) delivered earnings and revenue surprises of 28.57% and 4.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Reports First Quarter 2023 Net Sales of $290.5 MillionAchieves Record Quarterly Net IncomeRecord Quarterly Adjusted EBITDA Exceeds Company's First Quarter 2023 GuidanceReiterates 2023 Annual Outlook EAGLE, Idaho, May 09, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the first quarter ended March 31, 2023. Cord Christensen, PetIQ’s Chairman & CEO commented, "We are very pleased wi
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, May 9, 2023. To participa
PetIQ, Inc.'s ( NASDAQ:PETQ ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing investment...
PetIQ (PETQ) delivered earnings and revenue surprises of 37.50% and 4.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company GuidanceUpdates Adjusted EBITDA MethodologyReports Record Annual Cash from Operations of $48.0 MillionCompletes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook EAGLE, Idaho, Feb. 28, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, Fe
PetIQ, Inc. ( NASDAQ:PETQ ) shareholders will doubtless be very grateful to see the share price up 49% in the last...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PETQ vs. BSX: Which Stock Is the Better Value Option?
PETQ vs. BSX: Which Stock Is the Better Value Option?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
The mean of analysts' price targets for PetIQ (PETQ) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, PetIQ (PETQ) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund delivered a return of -3.09% net of fees, underperforming the -2.19% return of the Russell 2000 Index. Sector allocation contributed positively to the fund’s performance […]
The average of price targets set by Wall Street analysts indicates a potential upside of 108.3% in PetIQ (PETQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PetIQ ( NASDAQ:PETQ ) Third Quarter 2022 Results Key Financial Results Revenue: US$209.7m (flat on 3Q 2021). Net loss...
PetIQ (PETQ) delivered earnings and revenue surprises of 150% and 2.86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?